Symposium eyes global network for Type 2 diabetes research
January 21, 2014 - 6:16:23 am
DOHA: Qatar Biomedical Research Institute (QBRI), will host a symposium on ‘Systems Biology of Diabetes: Towards Precision Medicine’ to identify opportunities for creating a global network for research of Type 2 diabetes.
The symposium will bring together leading scientists from around the world to discuss new developments in the field of systems biology and genomic medicine for the understanding and treatment of diabetes on January 26 and 27 at Qatar National Convention Centre.
“Type 2 diabetes is a serious problem in Qatar, and QBRI is focused on better understanding this disease and finding innovative treatments for it,” said Dr Abdelali Haoudi, Executive Director, QBRI.
“The best approach for such research is not to work in isolation, but to collaborate with other researchers from local stakeholders’ institutions and around the world. By assembling this all-star team of systems biology and genomic medicine experts for two days in Doha, we hope to lay the foundation for a global network focused on innovative research for diabetes.”
Unlike traditional medicine, which offers a one-size-fits-all treatment approach, genomic medicine looks at diseases’ characteristics among genetically similar populations.
The ultimate goal of such research is to discover innovative therapies that are targeted at small, genetically related groups, giving rise to the term “precision medicine”.
“The quality of this symposium’s programme is superior to almost all of its kind in the field of diabetes,” said Dr Philippe Froguel, Senior Scientific Director of QBRI and one of the organisers of the event. The Peninsula